This filing details a Power of Attorney granted by Paul James Taylor, an officer of DXC Technology Co. (President, DXC), to a group of individuals including Matthew Fawcett. This power of attorney authorizes the appointed individuals to execute and file necessary documents, including Forms 3, 4, and 5, with the SEC on ...

This filing is an exhibit detailing a Power of Attorney granted by Sarah Watterson, a director of Rocket Companies, Inc. (RKT), to specific company officers. The purpose is to authorize these officers to execute and file SEC forms (3, 4, and 5) related to securities transactions on Watterson's behalf, in compliance wit...

This filing is an Exhibit Index 24.1, a Power of Attorney, related to a Form 3 filing for 3M CO. The reporting owner is Jennifer A. Cunningham, identified by CIK 0002147523, who is the EVP & Chief HR Officer of 3M CO. The filing is dated August 14, 2026, with the period of report being August 10, 2026. The power of att...

This filing is an Exhibit Index, specifically Exhibit 24.1, which is a Power of Attorney. The document is related to Bobby K. George, identified as the reporting owner with reporting owner CIK 0002108504. George is an Executive Vice President and Chief Information & Digital Officer of 3M CO (issuer CIK 0000066740, trad...

This filing contains a Power of Attorney appointment granted by David Ohm Turner to Jason Dammeyer. Dammeyer is authorized to act as Turner's attorney-in-fact for various SEC filings related to Alta Equipment Group Inc. This includes preparing and submitting Form ID applications for EDGAR access codes and managing the ...

This filing contains a Power of Attorney document appointing Melissa Brown, Colby Petersen, and Rachel Lybolt as attorneys-in-fact for Michael Ruppert. They are granted authority to handle U.S. Securities and Exchange Commission filings, including Form ID applications, passphrase updates, and EDGAR access. They can als...

This filing details a Power of Attorney granted by Steve Zhang, Co-Chief Financial Officer of Amber International Holding Ltd, to Binlin Cai and Hoi Ying Chau. This grants them the authority to execute and deliver necessary SEC filings, including Forms 3, 4, 5, and 144, related to Zhang's ownership and transactions in ...

LDB 2025 LLC, a reporting person associated with Apollo Global Management, Inc. (APO), has entered into a variable share forward transaction involving up to 2,000,000 shares of APO's common stock. This transaction, initiated on August 7, 2026, obligates LDB 2025 LLC to deliver shares or an equivalent cash amount to an ...

This filing is an initial statement of beneficial ownership of securities for Barbara Trebbi, who is a director at Bausch & Lomb Corp. The filing indicates that Ms. Trebbi has no securities owned. The document also includes a power of attorney from Debra E. Levin, acting as attorney-in-fact. The filing pertains to Baus...

This filing is an Exhibit 24, a Power of Attorney document for Jennifer Larson, Chief Financial Officer of Bicara Therapeutics Inc. (BCAX). The document, dated August 13, 2026, grants power of attorney to Claire Mazumdar, Ryan Cohlhepp, and Gabriela Morales-Rivera. They are authorized to execute SEC filings, including ...

This filing details the ownership of BioStem Technologies, Inc. (BSEM) by Jason Matuszewski, who holds multiple roles including CEO, Director, and a significant shareholder. The filing includes information on directly owned common stock, amounting to 1,278,433 shares. It also outlines various stock options and restrict...

This filing reports on a grant of 7,671 restricted stock units (RSUs) to Rayna Lesser Hannaway, a director at BioStem Technologies, Inc. These RSUs vest on August 27, 2026, and each unit represents a contingent right to one share of the company's common stock. The conversion or exercise price is detailed in footnote 2....

This filing details changes in beneficial ownership for Brandon Poe, Chief Financial Officer of BioStem Technologies, Inc. (BSEM). Poe directly holds 45,734 shares of common stock. The filing also discloses various stock options and restricted stock units granted to Poe. Notably, stock options with an exercise price of...

Kenneth Howard Warrington, Jr. reported beneficial ownership of BioStem Technologies, Inc. common stock. He directly owns 27,140 shares of common stock. Additionally, he holds a vested stock option to buy 7,462 shares of common stock with an exercise price of $1.80, expiring on March 29, 2032. He also holds 8,467 restr...

This filing details the ownership changes and holdings of Michael Fortunato, Chief Accounting Officer of BioStem Technologies, Inc. It includes information on stock options and restricted stock units (RSUs) with various vesting schedules and exercise prices. Specifically, there are vested and unvested stock options wit...

This filing details the ownership of securities by Barry Hassett, Chief Commercial Officer of BioStem Technologies, Inc. (BSEM). As of August 6, 2026, Hassett directly owns 4,503 shares of Common Stock. The filing also discloses various stock options and restricted stock units granted to Hassett, with specific vesting ...

This filing reports initial ownership of securities by Steven D. Sonenreich, a director at BioStem Technologies, Inc. (BSEM). Sonenreich acquired 7,671 restricted stock units (RSUs) on August 6, 2026. These RSUs vest on August 27, 2026, and each unit represents a contingent right to receive one share of the company's c...

This filing details transactions by Jodi Ungrodt, a director at BioStem Technologies, Inc. (BSEM). The report indicates Ungrodt holds 5,648 shares of Common Stock. Additionally, Ungrodt has been granted Restricted Stock Units (RSUs) which vest in two installments: May 27, 2026, and August 27, 2026. Each RSU corresponds...

This filing details a Power of Attorney granted by John Yetimoglu to Vlad Coric, Matthew Buten, George Clark, and Warren Volles. This authorization allows the appointed attorneys-in-fact to execute and file necessary documents, including Forms 3, 4, and 5, with the SEC on behalf of Mr. Yetimoglu. These forms are relate...

This filing details a Limited Power of Attorney granted by Rose P. Keravuori to Lisa Wager, Laurilee Kearnes, and Robert Wyman of Byrna Technologies Inc. The appointed attorneys-in-fact are authorized to prepare, execute, and file SEC forms (3, 4, and 5) related to Byrna Technologies securities, including amendments. T...

This filing is an initial statement of beneficial ownership of securities filed by Jonathan Peri, a director at Citius Oncology, Inc. The report covers transactions up to August 10, 2026. According to the filing, Mr. Peri holds 0 shares of Common Stock, and this is a direct ownership. The filing was signed on August 14...

This filing, dated August 8, 2026, reports on the ownership of CLARIVATE PLC (CLVT) by Matthew J. Lisowski, Senior VP, CAO. The filing indicates that Mr. Lisowski directly owns 79,898 ordinary shares following a transaction. The document also includes a Power of Attorney, signed on August 14, 2026, appointing Michael E...

This filing documents a Power of Attorney granted by Boudewijn Duinstra, EVP, Chief Risk Officer of Cboe Global Markets, Inc., to Patrick Sexton, Arthur Reinstein, and James Lisak. This grants them the authority to execute and file Forms 3, 4, and 5, and other required reports related to the undersigned's ownership, ac...

This filing is an Exhibit 24.1, a Power of Attorney, for Sandeep Deoji, Interim CFO of Coronado Global Resources Inc. The document appoints Barend J. van der Merwe, Philip Peacock, and Susan Casey as attorneys-in-fact. These attorneys are authorized to execute and file Forms 3, 4, and 5, including amendments, with the ...

This filing reports the initial statement of beneficial ownership of securities for Marat Shotbayev, Chief Logistics Officer of Freedom Holding Corp. The filing indicates that Mr. Shotbayev directly owns 252 shares of Common Stock, par value $0.001 per share, following a transaction. The report was filed on August 14, ...